ArticleThe New England journal of medicine2020
Stability and Viability of SARS-CoV-2.
Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Trial
- Assessing temporal correlation in environmental risk factors to design efficient area-specific COVID-19 regulations: Delhi based case study.Scientific reports · 2022Article
- SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern.Pathogens (Basel, Switzerland) · 2022Review
- COVID-19-from emerging global threat to ongoing pandemic crisis.Proceedings (Baylor University. Medical Center) · 2022Review
- Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019-2022.PloS one · 2022Article
- Presence and stability of SARS-CoV-2 on environmental currency and money cards in Utah reveals a lack of live virus.PloS one · 2022Article
- Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions.BMC infectious diseases · 2021Review
- Use of powered air-purifying respirator(PAPR) as part of protective equipment against SARS-CoV-2-a narrative review and critical appraisal of evidence.American journal of infection control · 2021Review
- SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.Microorganisms · 2021Review
- Differences in the clinical characteristics and outcomes of COVID-19 patients in the epicenter and peripheral areas of the pandemic from China: a retrospective, large-sample, comparative analysis.BMC infectious diseases · 2021Article
- Role of nanotechnology in facing SARS-CoV-2 pandemic: Solving crux of the matter with a hopeful arrow in the quiver.Sensors international · 2021Review
- SARS-CoV-2 viability under different meteorological conditions, surfaces, fluids and transmission between animals.Environmental research · 2021Review
- COVID 19: challenges for virologists in the food industry.Microbial biotechnology · 2020Review
- The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020Review
- The COVID-19 pandemic and face shields.The British journal of surgery · 2020Article
- Coronavirus disease 2019 in chronic kidney disease.Clinical kidney journal · 2020Review
- Aerosol Transmission of SARS-CoV-2: Physical Principles and Implications.Frontiers in public healthReview
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.